Opdivo (nivolumab)
pCPA File Number:
21086
Negotiation Status:
Negotiations were not pursued
Indication(s):
Hepatocellular Carcinoma (HCC) in adults after prior therapy
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CDA-AMC Project Number:
PC0134-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: